# Weight Loss With Intensive Lifestyle Modifications Plus Bariatric Surgery Versus Liraglutide 3 mg

> **NCT03534310** · NA · COMPLETED · sponsor: **Catholic University of the Sacred Heart** · enrollment: 75 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** LIRAGLUTIDE 3 Mg/0.5 mL (18 Mg/3 mL) SUB-Q PEN INJECTOR (ML)
- **OTHER:** lifestyle modification
- **OTHER:** sleeve gastrectomy

## Key facts

- **NCT ID:** NCT03534310
- **Lead sponsor:** Catholic University of the Sacred Heart
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11-02
- **Primary completion:** 2017-01-31
- **Final completion:** 2017-04-10
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2018-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03534310

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03534310, "Weight Loss With Intensive Lifestyle Modifications Plus Bariatric Surgery Versus Liraglutide 3 mg". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03534310. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*